Archives

by in
Entry Author Date Location
The Biotech IPO Scorecard: Who’s Up, Who’s Down in 2013 06/03/13 National
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More 05/17/13 San Diego
Ambit Slices Price of IPO, Increases Number of Shares Offered 05/16/13 San Diego
Ambit Biosciences Secures $64,800,000 New Financing 05/16/13 San Diego
San Diego Life Sciences Roundup: Receptos, Arena, NuVasive, & More 05/09/13 San Diego
San Diego’s Receptos, Ambit Biosciences, Get Ready for IPO Debuts 05/06/13 San Diego
Blueprint Medicines Combs Through Genome for the Next Gleevec(s) 03/20/13 Boston
San Diego Life Sciences Roundup: Ambit, Lithera, Histogen, & More 03/14/13 San Diego
Ambit Still Committed to Leukemia Drug After Astellas Ends Pact 03/12/13 San Diego
San Diego Life Sciences Roundup: IPOs, ResMed, Ventrix, CovX, & More 02/21/13 San Diego
San Diego Life Sciences Roundup: Deals at MEI Pharma, Auspex, Ambit 11/09/12 San Diego
San Diego’s Ambit Biosciences Raises $25M to Advance Leukemia Drug 11/06/12 San Diego
Ambit Biosciences Obtains $50,000,000 New Funding 11/06/12 San Diego
BioMed Realty Remains Mostly Mum About New BioMed Ventures 06/20/12 San Diego
Ambit Biosciences Receives $7,066,803 New Round 05/31/12 San Diego
SD Tech Roundup: ServiceNow Files IPO, On-Ramp Wireless, SwoopThat 04/04/12 San Diego
Martino Joins Ambit, Nordhoff Leaves Gen-Probe, Swarmology Raises $1.2M, and More San Diego Life Sciences News 11/17/11 San Diego
CMEA’s Jain on San Diego’s Innovation Economy, E&Y Reports on IPO Activity, Wildcat Discovery Gets $7.5M, & More San Diego BizTech News 08/01/11 San Diego
Allozyne Looks to Rustle Up Interest on Wall Street With Backdoor IPO 07/13/11 Seattle
BioNanomatrix Moves HQ, Awarepoint CEO Talks Strategy, Ambit Raises $30 Million, & More San Diego Life Sciences News 06/16/11 San Diego
Ambit Raises $30M Venture Round, After Pulling Plug on IPO 06/10/11 San Diego
Ambit Biosciences Receives $30,000,000 Series D Funding Round 06/10/11 San Diego
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News 06/09/11 San Diego
Ambit Withdraws IPO 06/08/11 San Diego
IPO Pipeline Pumps Up the Volume in First Quarter 05/23/11 National
Ambit Files for IPO, Arena Pharmaceuticals Says Weight-Loss Drug on Track, ESRI Launches Medical Place History Map App, & More San Diego Life Sciences News 11/12/10 San Diego
Ambit Biosciences Seeks $86M IPO as Market Warms Up 11/08/10 San Diego
Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News 10/21/10 San Diego
Ambit Bio Raises $15M 10/19/10 San Diego
Ambit Biosciences Lands $14,999,327 New Funding 10/19/10 San Diego
Page 1 of 2 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.